Literature DB >> 20506251

Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study.

Tracy Frech1, Dinesh Khanna, Boaz Markewitz, Geraldine Mineau, Richard Pimentel, Allen Sawitzke.   

Abstract

OBJECTIVE: To investigate the familiality of systemic sclerosis (SSc) in relation to Raynaud's phenomenon (RP) (a marker of vasculopathy), other autoimmune inflammatory disease, and fibrotic interstitial lung disease (ILD).
METHODS: A genealogic resource, the Utah Population Database (UPDB), was used to test heritability of RP, other autoimmune disease, and ILD. Diseases were defined by International Classification of Diseases, Ninth Revision codes and identified from statewide discharge data, the University of Utah Health Science Center Enterprise Data Warehouse, and death certificates and were linked to the UPDB for analysis. Familial standardized incidence ratio (FSIR), relative risks (RRs) to first-, second-, third-, and fourth-degree relatives for SSc, RP, other autoimmune disease, and ILD (with 95% confidence intervals [95% CIs]), and population attributable risk (PAR) were calculated.
RESULTS: A software kinship analysis tool was used to analyze 1,037 unique SSc patients. Fifty SSc families had significant FSIRs, ranging from 2.07 to 17.60. The adjusted PAR was approximately 8%. The RRs were significant for other autoimmune disease in the first-degree relatives (2.49 [95% CI 1.99-3.41], P = 2.42 x 10(-15)) and second-degree relatives (1.48 [95% CI 1.34-2.39], P = 0.002), for RP in first-degree relatives (6.38 [95% CI 3.44-11.83], P = 4.04 x 10(-9)) and second-degree relatives (2.39 [95% CI 1.21-4.74], P = 0.012), and for ILD in first-degree relatives (1.53 [95% CI 1.04-2.26], P = 0.03), third-degree relatives (1.47 [95% CI 1.18-1.82], P = 0.0004), and fourth-degree relatives (1.2 [95% CI 1.06-1.35], P = 0.004).
CONCLUSION: These data suggest that SSc pedigrees include more RP, autoimmune inflammatory disease, and ILD than would be expected by chance. In SSc pedigrees, genetic predisposition to vasculopathy is the most frequent risk among first-degree relatives.

Entities:  

Mesh:

Year:  2010        PMID: 20506251      PMCID: PMC2956122          DOI: 10.1002/art.27469

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  30 in total

Review 1.  Autoimmune diseases.

Authors:  A Davidson; B Diamond
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

2.  Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices.

Authors:  L B Jorde
Journal:  Ann Hum Genet       Date:  1989-10       Impact factor: 1.670

3.  Measures of familial aggregation as predictors of breast-cancer risk.

Authors:  K M Boucher; R A Kerber
Journal:  J Epidemiol Biostat       Date:  2001

4.  Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon.

Authors:  P Lee; J Sarkozi; A A Bookman; E C Keystone; S K Armstrong
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

5.  Method for calculating risk associated with family history of a disease.

Authors:  R A Kerber
Journal:  Genet Epidemiol       Date:  1995       Impact factor: 2.135

6.  Estimating the population attributable risk for multiple risk factors using case-control data.

Authors:  P Bruzzi; S B Green; D P Byar; L A Brinton; C Schairer
Journal:  Am J Epidemiol       Date:  1985-11       Impact factor: 4.897

7.  Genetic distances between the Utah Mormons and related populations.

Authors:  T McLellan; L B Jorde; M H Skolnick
Journal:  Am J Hum Genet       Date:  1984-07       Impact factor: 11.025

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies.

Authors:  Carol Feghali-Bostwick; Thomas A Medsger; Timothy M Wright
Journal:  Arthritis Rheum       Date:  2003-07

10.  Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.

Authors:  Maureen D Mayes; James V Lacey; Jennifer Beebe-Dimmer; Brenda W Gillespie; Brenda Cooper; Timothy J Laing; David Schottenfeld
Journal:  Arthritis Rheum       Date:  2003-08
View more
  21 in total

Review 1.  The pathogenesis, diagnosis and treatment of Raynaud phenomenon.

Authors:  Ariane L Herrick
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

2.  Autophagy is a key feature in the pathogenesis of systemic sclerosis.

Authors:  Tracy Frech; Ivana De Domenico; Maureen A Murtaugh; Monica P Revelo; Dean Y Li; Allen D Sawitzke; Stavros Drakos
Journal:  Rheumatol Int       Date:  2013-08-11       Impact factor: 2.631

3.  Mining electronic health records: an additional perspective.

Authors:  John F Hurdle; Ken R Smith; Geraldine P Mineau
Journal:  Nat Rev Genet       Date:  2013-01       Impact factor: 53.242

Review 4.  The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.

Authors:  Jasper C A Broen; Timothy R D J Radstake; Marzia Rossato
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

Review 5.  The genetics of scleroderma.

Authors:  Javier Martin; Carmen Fonseca
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

Review 6.  The genetics of systemic sclerosis.

Authors:  Sandeep K Agarwal
Journal:  Discov Med       Date:  2010-08       Impact factor: 2.970

7.  The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.

Authors:  Ada Man; Yanyan Zhu; Yuqing Zhang; Maureen Dubreuil; Young Hee Rho; Christine Peloquin; Robert W Simms; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

8.  Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives.

Authors:  Fabian A Mendoza; Maryah Mansoor; Sergio A Jimenez
Journal:  Expert Opin Orphan Drugs       Date:  2015-11-23       Impact factor: 0.694

9.  The vascular microenvironment and systemic sclerosis.

Authors:  Tracy Frech; Nathan Hatton; Boaz Markewitz; Mary Beth Scholand; Richard Cawthon; Amit Patel; Allen Sawitzke
Journal:  Int J Rheumatol       Date:  2010-08-10

Review 10.  How do autoimmune diseases cluster in families? A systematic review and meta-analysis.

Authors:  Jorge Cárdenas-Roldán; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  BMC Med       Date:  2013-03-18       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.